Yüklüyor......
Immune Responses to Plasma-Derived Versus Recombinant FVIII Products
The most severe side effect of hemophilia treatment is the inhibitor development occurring in 30% of patients, during the earliest stages of treatment with factor (F)VIII concentrates. These catastrophic immune responses rapidly inactivate the infused FVIII, rendering the treatment ineffective. This...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7862552/ https://ncbi.nlm.nih.gov/pubmed/33552050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.591878 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|